Metabolic factors may identify individuals prone to develop statin-related diabetes

19-9-2016 • Kohli P et al., Am J Cardiol 2016
The diabetogenic impact of statin treatment is relatively modest, but is aggravated if plasma glucose, TG concentrations and BMI increase. Read more

Established risk factors cannot explain gender differences in MI risk

15-9-2016 • Albrektsen G et al., JAMA Intern Med 2016
Compared with women, men have approximately twice the risk of MI. This difference cannot be explained by established CHD risk factors, it persists throughout life but declines with age. Read more
News • 7-9-2016

Important debate about interpretation of SPRINT-data at ESC congress

ESC 2016 During a debate, SPRINT received substantial critique, with implications for the interpretation of the results and for the question whether these should influence new guidelines. Read more
News • 4-9-2016

Weekly remote monitoring of CIED in heart failure does not yield benefit

ESC 2016 In the REM-HF study, weekly remote monitoring of CIED did not affect mortality or hospitalization for HF, in comparison with standard therapy. Read more
News • 4-9-2016

Remote monitoring CRT reduces clinic visits, without clinical benefit

ESC 2016 Remote monitoring of a CRT in HF patients did not result in clinical benefit in the MORE-CARE study, but a reduction of clinic visits yielded a cost saving. Read more

Real-world safety data show differences between anticoagulants in AF patients

23-8-2016 • Lip GYH et al., Thromb Haemost 2016
In a real-world observational study using propensity score matched cohorts, apixaban initiation was associated with significantly lower risk of major bleeding compared to warfarin and rivaroxaban. Read more
News • 18-9-2016

EPCCS consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care

General practitioners representing various European countries discussed recent developments in the SPAF field, and specific implications for primary care in an expert meeting. This meeting resulted in a practical guidance for European GPs. Read more

Very low BP in CAD patients associated with increased CV morbidity and mortality

12-9-2016 • Vidal-Petiot E et al., Lancet 2016
In the large observational CLARIFY cohort of patients with hypertension and CAD, SBP< 120 mmHg and DBP<70 mmHg were associated with increased CV outcomes, even after multiple adjustments. Read more
News • 5-9-2016

Study on long term exposure to low LDL-c and low SBP suggests that most CV events are preventable

ESC 2016 Exposure to low levels of LDL-c and SBP have independent, multiplicative and cumulative causal effects on CV risk, according to a Mendelian randomisation study. Read more
News • 4-9-2016

CPAP did not lower CV events in patients with obstructive sleep apnea

ESC 2016 Coronary or cerebrovascular patients with obstructive sleep apnea did not show improvement in CV mortality with CPAP therapy, but there was a trend towards fewer cerebrovascular events and better mood. Read more

Different risks of HF, CVD, and mortality associated with use of different antidiabetic drugs

24-8-2016 • Hippisley-Cox J, et al. BMJ 2016
In an open cohort study of 469 688 diabetic patients in 1243 UK primary care practices, clinically relevant differences between diabetes drugs and the risk for heart failure, cardiovascular disease, and all-cause mortality were observed. Read more

To screen or not to screen for FH in childhood

18-8-2016 • Lozano et al., JAMA 2016
Identification of and lipid-lowering treatment of familial hypercholesterolemia in childhood reduces lipid concentrations in the short term, with little evidence of harm. Long-term evidence is lacking. Read more

Upcoming meetings

Meeting reports & resources

EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
EPCCS 2013 Report of 6th Annual EPCCS meeting held in London
EPCCS 2012 Report of 5th Annual EPCCS meeting held in Athens
All meeting reports...